Discover
ADC
Agree Realty Corporation
76.28
200 x undefined
200 x undefined
bid
ask
+
0.54
0.71%
200 @ 04:00 PM
76.37 +0.09 (0.12%)
| Ytd | 5.90% | |
| 1y | 4.75% |
75.99
day range
76.72
69.56
52 week range
82.08
| Open | 76.11 | Prev Close | 75.74 | Low | 75.99 | High | 76.72 | Mkt Cap | 9.19B |
| Vol | 711.00K | Avg Vol | 1.14M | EPS | 1.85 | P/E | 41.23 | Forward P/E | 39.05 |
| Beta | 0.48 | Short Ratio | 0.01 | Inst. Own | 120.49% | Dividend | 3.20 | Div Yield | 4.23 |
| Ex Div Date | 06-30 | Earning | 07-30 | 50-d Avg | 75.32 | 200-d Avg | 74.66 | 1yr Est | 84.56 |
ADC News
prnewswire.com
ADC Therapeutics Announces New Employee Inducement Grant
LAUSANNE, Switzerland, July 1, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-s
gurufocus.com
Agree Realty Announces Second Quarter 2026 Earnings Release Date and Conference Call Information
Agree Realty Corporation (NYSE: ADC) (the âCompanyâ) today announced that it will release its se
businesswire.com
Agree Realty Announces Second Quarter 2026 Earnings Release Date and Conference Call Information
ROYAL OAK, Mich.--(BUSINESS WIRE)--Agree Realty Corporation (NYSE: ADC) (the “Company”) today announ
prnewswire.com
ADC Therapeutics Announces Completion of Enrollment in LOTIS-7 Phase 1b ZYNLONTA® Combination Trial
100 r/r DLBCL patients treated at the selected 150 µg/kg dose of ZYNLONTA® plus glofitamab Full data
prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA
NEW YORK, June 25, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
benzinga.com
Agree Realty And Global Net Lease: One Yields 4%, One Yields 8%. The Balance Sheet Sets The Spread.
benzinga.com
Alpha Buying: Insiders Are Buying Real Estate While Everyone Else Panics